BioCentury | Feb 12, 2001
Clinical News

VirtualPhenotype: Marketed

...for anti-HIV drugs. Data were presented at the Retroviruses and Opportunistic Infections conference in Chicago. Vircolab...
BioCentury | Aug 14, 2000
Company News

Virco Group other research news

...Virco's VircoLab subsidiary (Baltimore, Md.) received a $400,000 contract from the Centers for Disease Control and...
BioCentury | Feb 7, 2000
Clinical News

Antivirogram: Marketed

...San Francisco. Antivirogram is marketed in the U.S. at a cost of $800 per assay. Vircolab...
Items per page:
1 - 3 of 3
BioCentury | Feb 12, 2001
Clinical News

VirtualPhenotype: Marketed

...for anti-HIV drugs. Data were presented at the Retroviruses and Opportunistic Infections conference in Chicago. Vircolab...
BioCentury | Aug 14, 2000
Company News

Virco Group other research news

...Virco's VircoLab subsidiary (Baltimore, Md.) received a $400,000 contract from the Centers for Disease Control and...
BioCentury | Feb 7, 2000
Clinical News

Antivirogram: Marketed

...San Francisco. Antivirogram is marketed in the U.S. at a cost of $800 per assay. Vircolab...
Items per page:
1 - 3 of 3